Revvity Inc. (NYSE:RVTY) Given Consensus Rating of “Hold” by Brokerages

Revvity Inc. (NYSE:RVTY) has earned a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $108.3333.

A number of research analysts have commented on RVTY shares. Sanford C. Bernstein started coverage on shares of Revvity in a research note on Friday. They issued a “market perform” rating and a $115.00 price objective on the stock. Barclays lifted their price objective on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. JPMorgan Chase & Co. dropped their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Weiss Ratings upgraded shares of Revvity from a “sell (d)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. Finally, TD Cowen lifted their price objective on shares of Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th.

Revvity Trading Down 0.1%

NYSE RVTY opened at $111.11 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The firm has a market cap of $12.40 billion, a PE ratio of 53.16, a P/E/G ratio of 2.43 and a beta of 1.11. Revvity has a one year low of $81.22 and a one year high of $118.30. The firm’s fifty day moving average is $98.23 and its two-hundred day moving average is $97.88.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The company had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period in the previous year, the business posted $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Analysts expect that Revvity will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be issued a $0.07 dividend. The ex-dividend date of this dividend is Friday, July 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is presently 13.40%.

Institutional Trading of Revvity

Hedge funds and other institutional investors have recently made changes to their positions in the company. JPMorgan Chase & Co. boosted its holdings in Revvity by 15.2% during the third quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock worth $44,821,000 after buying an additional 67,662 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in Revvity during the third quarter worth about $15,128,000. Neuberger Berman Group LLC raised its position in Revvity by 4,598.9% during the third quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock worth $40,358,000 after acquiring an additional 450,648 shares during the last quarter. Elo Mutual Pension Insurance Co raised its position in Revvity by 46.2% during the third quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock worth $1,683,000 after acquiring an additional 6,066 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its position in Revvity by 39.0% during the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after acquiring an additional 596,436 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.